Cochlear Implants Market in US 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	151 Pages	TechNavio	February, 2025	INF19639230

Best Price Guarantee
Price	from $2,500
Length	151 Pages
Publisher	TechNavio
Published Date	February, 2025
SKU	INF19639230

Cochlear Implants Market In US 2025-2029

The cochlear implants market in US is forecasted to grow by USD 415.5 million during 2024-2029, accelerating at a CAGR of 11.8% during the forecast period. The report on the cochlear implants market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of hearing loss, favorable insurance and reimbursement policies, and increased awareness and early diagnosis of hearing loss.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit - https://www.technavio.com/report/report/us-cochlear-implants-market-industry-analysis

Technavio's cochlear implants market in US is segmented as below:

By Product

Unilateral
Bilateral

By Type

Adult
Pediatric

By End-user

Hospitals
Specialty clinics
Ambulatory surgical centers

By Geographical Landscape

North America

This study identifies the technological advancements as one of the prime reasons driving the cochlear implants market in US growth during the next few years. Also, increasing focus on aesthetic appearance and customization and expansion of candidacy indications for cochlear implants will lead to sizable demand in the market.

The report on the cochlear implants market in US covers the following areas:

Cochlear Implants Market in US sizing
Cochlear Implants Market in US forecast
Cochlear Implants Market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cochlear implants market in US vendors that include Advanced Bionics AG, Cochlear Ltd., Envoy Medical Corp., MED EL Medical Electronics., Medtronic PLC, Oticon Medical AS, and ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD.. Also, the cochlear implants market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US: Year-over-year growth 2024-2029 (%); Data Table on US: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Cochlear Implants Market in US 2019 - 2023; Historic Market Size - Data Table on Cochlear Implants Market in US 2019 - 2023 ($ million); 5.2 Product segment analysis 2019 - 2023; Historic Market Size - Product Segment 2019 - 2023 ($ million); 5.3 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ million); 5.4 End-user segment analysis 2019 - 2023; Historic Market Size - End-user Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on Cochlear Implants Market in US
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2024-2029 (%); Data Table on Product - Market share 2024-2029 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 Unilateral - Market size and forecast 2024-2029; Chart on Unilateral - Market size and forecast 2024-2029 ($ million); Data Table on Unilateral - Market size and forecast 2024-2029 ($ million); Chart on Unilateral - Year-over-year growth 2024-2029 (%); Data Table on Unilateral - Year-over-year growth 2024-2029 (%); 8.4 Bilateral - Market size and forecast 2024-2029; Chart on Bilateral - Market size and forecast 2024-2029 ($ million); Data Table on Bilateral - Market size and forecast 2024-2029 ($ million); Chart on Bilateral - Year-over-year growth 2024-2029 (%); Data Table on Bilateral - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Type: 9.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 9.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 9.3 Adult - Market size and forecast 2024-2029; Chart on Adult - Market size and forecast 2024-2029 ($ million); Data Table on Adult - Market size and forecast 2024-2029 ($ million); Chart on Adult - Year-over-year growth 2024-2029 (%); Data Table on Adult - Year-over-year growth 2024-2029 (%); 9.4 Pediatric - Market size and forecast 2024-2029; Chart on Pediatric - Market size and forecast 2024-2029 ($ million); Data Table on Pediatric - Market size and forecast 2024-2029 ($ million); Chart on Pediatric - Year-over-year growth 2024-2029 (%); Data Table on Pediatric - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by End-user: 10.1 Market segments; Chart on End-user - Market share 2024-2029 (%); Data Table on End-user - Market share 2024-2029 (%); 10.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 10.3 Hospitals - Market size and forecast 2024-2029; Chart on Hospitals - Market size and forecast 2024-2029 ($ million); Data Table on Hospitals - Market size and forecast 2024-2029 ($ million); Chart on Hospitals - Year-over-year growth 2024-2029 (%); Data Table on Hospitals - Year-over-year growth 2024-2029 (%); 10.4 Specialty clinics - Market size and forecast 2024-2029; Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million); Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million); Chart on Specialty clinics - Year-over-year growth 2024-2029 (%); Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%); 10.5 Ambulatory surgical centers - Market size and forecast 2024-2029; Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million); Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million); Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%); Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%); 10.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 Advanced Bionics AG; Advanced Bionics AG - Overview; Advanced Bionics AG - Product / Service; Advanced Bionics AG - Key offerings; SWOT; 14.5 Cochlear Ltd.; Cochlear Ltd. - Overview; Cochlear Ltd. - Business segments; Cochlear Ltd. - Key news; Cochlear Ltd. - Key offerings; Cochlear Ltd. - Segment focus; SWOT; 14.6 Envoy Medical Corp.; Envoy Medical Corp. - Overview; Envoy Medical Corp. - Product / Service; Envoy Medical Corp. - Key offerings; SWOT; 14.7 MED EL Medical Electronics.; MED EL Medical Electronics. - Overview; MED EL Medical Electronics. - Product / Service; MED EL Medical Electronics. - Key news; MED EL Medical Electronics. - Key offerings; SWOT; 14.8 Medtronic Plc; Medtronic Plc - Overview; Medtronic Plc - Business segments; Medtronic Plc - Key news; Medtronic Plc - Key offerings; Medtronic Plc - Segment focus; SWOT; 14.9 Oticon Medical AS; Oticon Medical AS - Overview; Oticon Medical AS - Product / Service; Oticon Medical AS - Key offerings; SWOT; 14.10 ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD.; ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD. - Overview; ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD. - Product / Service; ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD. - Key offerings; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Product; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Company Market Positioning; Exhibits8: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits9: Overview on criticality of inputs and factors of differentiation; Exhibits10: Overview on factors of disruption; Exhibits11: Impact of drivers and challenges in 2024 and 2029; Exhibits12: Parent Market; Exhibits13: Data Table on - Parent Market; Exhibits14: Market characteristics analysis; Exhibits15: Value chain analysis; Exhibits16: Offerings of companies included in the market definition; Exhibits17: Market segments; Exhibits18: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits19: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits20: Chart on US: Year-over-year growth 2024-2029 (%); Exhibits21: Data Table on US: Year-over-year growth 2024-2029 (%); Exhibits22: Historic Market Size - Data Table on Cochlear Implants Market in US 2019 - 2023 ($ million); Exhibits23: Historic Market Size - Product Segment 2019 - 2023 ($ million); Exhibits24: Historic Market Size - Type Segment 2019 - 2023 ($ million); Exhibits25: Historic Market Size - End-user Segment 2019 - 2023 ($ million); Exhibits26: Five forces analysis - Comparison between 2024 and 2029; Exhibits27: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits28: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits29: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits30: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits31: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits32: Chart on Market condition - Five forces 2024 and 2029; Exhibits33: Chart on Product - Market share 2024-2029 (%); Exhibits34: Data Table on Product - Market share 2024-2029 (%); Exhibits35: Chart on Comparison by Product; Exhibits36: Data Table on Comparison by Product; Exhibits37: Chart on Unilateral - Market size and forecast 2024-2029 ($ million); Exhibits38: Data Table on Unilateral - Market size and forecast 2024-2029 ($ million); Exhibits39: Chart on Unilateral - Year-over-year growth 2024-2029 (%); Exhibits40: Data Table on Unilateral - Year-over-year growth 2024-2029 (%); Exhibits41: Chart on Bilateral - Market size and forecast 2024-2029 ($ million); Exhibits42: Data Table on Bilateral - Market size and forecast 2024-2029 ($ million); Exhibits43: Chart on Bilateral - Year-over-year growth 2024-2029 (%); Exhibits44: Data Table on Bilateral - Year-over-year growth 2024-2029 (%); Exhibits45: Market opportunity by Product ($ million); Exhibits46: Data Table on Market opportunity by Product ($ million); Exhibits47: Chart on Type - Market share 2024-2029 (%); Exhibits48: Data Table on Type - Market share 2024-2029 (%); Exhibits49: Chart on Comparison by Type; Exhibits50: Data Table on Comparison by Type; Exhibits51: Chart on Adult - Market size and forecast 2024-2029 ($ million); Exhibits52: Data Table on Adult - Market size and forecast 2024-2029 ($ million); Exhibits53: Chart on Adult - Year-over-year growth 2024-2029 (%); Exhibits54: Data Table on Adult - Year-over-year growth 2024-2029 (%); Exhibits55: Chart on Pediatric - Market size and forecast 2024-2029 ($ million); Exhibits56: Data Table on Pediatric - Market size and forecast 2024-2029 ($ million); Exhibits57: Chart on Pediatric - Year-over-year growth 2024-2029 (%); Exhibits58: Data Table on Pediatric - Year-over-year growth 2024-2029 (%); Exhibits59: Market opportunity by Type ($ million); Exhibits60: Data Table on Market opportunity by Type ($ million); Exhibits61: Chart on End-user - Market share 2024-2029 (%); Exhibits62: Data Table on End-user - Market share 2024-2029 (%); Exhibits63: Chart on Comparison by End-user; Exhibits64: Data Table on Comparison by End-user; Exhibits65: Chart on Hospitals - Market size and forecast 2024-2029 ($ million); Exhibits66: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million); Exhibits67: Chart on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits68: Data Table on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits69: Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million); Exhibits70: Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million); Exhibits71: Chart on Specialty clinics - Year-over-year growth 2024-2029 (%); Exhibits72: Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%); Exhibits73: Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million); Exhibits74: Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million); Exhibits75: Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%); Exhibits76: Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%); Exhibits77: Market opportunity by End-user ($ million); Exhibits78: Data Table on Market opportunity by End-user ($ million); Exhibits79: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits80: Impact of drivers and challenges in 2024 and 2029; Exhibits81: Overview on criticality of inputs and factors of differentiation; Exhibits82: Overview on factors of disruption; Exhibits83: Impact of key risks on business; Exhibits84: Companies covered; Exhibits85: Company ranking index; Exhibits86: Matrix on companies position and classification; Exhibits87: Advanced Bionics AG - Overview; Exhibits88: Advanced Bionics AG - Product / Service; Exhibits89: Advanced Bionics AG - Key offerings; Exhibits90: SWOT; Exhibits91: Cochlear Ltd. - Overview; Exhibits92: Cochlear Ltd. - Business segments; Exhibits93: Cochlear Ltd. - Key news; Exhibits94: Cochlear Ltd. - Key offerings; Exhibits95: Cochlear Ltd. - Segment focus; Exhibits96: SWOT; Exhibits97: Envoy Medical Corp. - Overview; Exhibits98: Envoy Medical Corp. - Product / Service; Exhibits99: Envoy Medical Corp. - Key offerings; Exhibits100: SWOT; Exhibits101: MED EL Medical Electronics. - Overview; Exhibits102: MED EL Medical Electronics. - Product / Service; Exhibits103: MED EL Medical Electronics. - Key news; Exhibits104: MED EL Medical Electronics. - Key offerings; Exhibits105: SWOT; Exhibits106: Medtronic Plc - Overview; Exhibits107: Medtronic Plc - Business segments; Exhibits108: Medtronic Plc - Key news; Exhibits109: Medtronic Plc - Key offerings; Exhibits110: Medtronic Plc - Segment focus; Exhibits111: SWOT; Exhibits112: Oticon Medical AS - Overview; Exhibits113: Oticon Medical AS - Product / Service; Exhibits114: Oticon Medical AS - Key offerings; Exhibits115: SWOT; Exhibits116: ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD. - Overview; Exhibits117: ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD. - Product / Service; Exhibits118: ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD. - Key offerings; Exhibits119: SWOT; Exhibits120: Inclusions checklist; Exhibits121: Exclusions checklist; Exhibits122: Currency conversion rates for US$; Exhibits123: Research methodology; Exhibits124: Information sources; Exhibits125: Data validation; Exhibits126: Validation techniques employed for market sizing; Exhibits127: Data synthesis; Exhibits128: 360 degree market analysis; Exhibits129: List of abbreviations